Journal Information

Statistics

Follow this link to access the full text of the article

Original
Evaluación económica de rituximab en combinación con fludarabina y ciclofosfamida en comparación con fludarabina y ciclofosfamida en el tratamiento de la leucemia linfática crónica
Economic evaluation of rituximab added to fludarabine plus cyclophosphamide versus fludarabine plus cyclophosphamide for the treatment of chronic lymphocytic leukemia
Luis Felipe Casadoa, José Antonio García Marcob, Florinda Gilsanzc, Marcos Gonzálezd, Eduardo Ríose, Javier de la Sernac, Álvaro Urbanof, Vicente Vicenteg, Carlos Rubio-Terrésh, Antonio J. Castroi,
Corresponding author
antonio_jesus.castro@roche.com

Autor para correspondencia.
a Hospital Virgen de la Salud, Toledo, España
b Hospital Universitario Puerta Hierro, Madrid, España
c Hospital Universitario 12 de Octubre, Madrid, España
d Hospital Clínico Universitario, Salamanca, España
e Hospital Universitario Nuestra Señora de Valme, Sevilla, España
f Hospital Universitario Virgen del Rocío, Sevilla, España
g Hospital General Universitario, Murcia, España
h Health Value, Madrid, España
i Roche Farma, Madrid, España
Ver más
Read
1583
Times
was read the article
475
Total PDF
1108
Total HTML
Share statistics
Article information
ISSN: 02139111
Original language: Spanish
The statistics are updated each day
Year/Month Html Pdf Total
2024 December 61 12 73
2024 November 93 48 141
2024 October 79 41 120
2024 September 85 28 113
2024 August 87 32 119
2024 July 55 28 83
2024 June 56 13 69
2024 May 50 27 77
2024 April 56 18 74
2024 March 85 34 119
2024 February 48 29 77
2024 January 48 17 65
2023 December 43 19 62
2023 November 40 21 61
2023 October 36 18 54
2023 September 34 25 59
2023 August 37 14 51
2023 July 62 22 84
2023 June 32 15 47
2023 May 21 14 35
Show all

Follow this link to access the full text of the article

Idiomas
Gaceta Sanitaria
es en

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?